Stay updated on KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.

Latest updates to the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page
- CheckyesterdayChange DetectedThe status of the study shifted from Active, not recruiting to Completed as of 2026-09-04, and the prior recruiting indicator was removed on 2026-07-30. This update indicates that enrollment and study activities have concluded.SummaryDifference0.1%

- Check8 days agoChange DetectedA funding/identifier line for 2023 U.S. NIH Grant/Contract was added, and the page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.6.5 is now displayed, indicating an update to the study record. This appears to be an administrative maintenance update rather than a substantive change to the study data or eligibility.SummaryDifference0.0%

- Check36 days agoChange DetectedA new Hangzhou site in Zhejiang, China (310009) with status Completed was added on 2026-07-30, and an existing Hangzhou site (310016) with status Active, not recruiting was removed on 2026-07-14. These changes update the study's site roster and reflect shifting enrollment activity.SummaryDifference0.2%

- Check43 days agoChange DetectedRevision: v3.6.4 is now shown, replacing the previous v3.6.3 tag to reflect an updated version of the page.SummaryDifference0.0%

- Check51 days agoChange DetectedDifference0.2%

Stay in the know with updates to KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.